Results 281 to 290 of about 230,151 (306)

T-cell acute lymphoblastic leukemia: therapeutic outcomes in adolescents and young adults. [PDF]

Ann Hematol
Azza E, Ben Othmen A, Bahri M, Hsasna R, Ben Lakhel R, Ben Abdennebi Y, Aissaoui L.   +6 more
europepmc   +1 more source

Hypermethylation of lysosomal-associated genes LAMP1 and LAMP2 compromises lysosome function in patients with acute lymphoblastic leukemia. [PDF]

Immunol Res
Refaai R, Fouda S, Hefni DM, Ragab D, Elshamy AM, Shoaib H, Guirgis AA, Khalil H.   +7 more
europepmc   +1 more source

Preclinical and Case Series Studies on the Combination of Venetoclax with Epigenetic Drugs in T-Cell Acute Lymphoblastic Leukemia. [PDF]

Cancer Manag Res
Zheng B, Fu J, Wang Y, Wu J, Wang J, Li H.   +5 more
europepmc   +1 more source

Correction to "Ex vivo drug responses and molecular profiles of 597 pediatric acute lymphoblastic leukemia patients". [PDF]

Hemasphere
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Critical care management of chimeric antigen receptor T‐cell therapy recipients

Ca-A Cancer Journal for Clinicians, 2022
Alexander Shimabukuro-Vornhagen, Boris Böll, Victoria Metaxa   +2 more
exaly  

Clinical practice guideline and expert consensus recommendations for rehabilitation among children with cancer: A systematic review

Ca-A Cancer Journal for Clinicians, 2023
Allison J L'hotta
exaly  

CAR T cells with dual targeting of CD19 and CD22 in pediatric and young adult patients with relapsed or refractory B cell acute lymphoblastic leukemia: a phase 1 trial

Nature Medicine, 2021
Sara Ghorashian, Ajay Vora, Giovanna Lucchini   +2 more
exaly  

Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials

Nature Medicine, 2023
Timothy A Yap, Naval G Daver
exaly